Cutaneous desmop astic melanoma - Reappraisal of morphologic heterogeneity and prognostic factors

被引:150
作者
Busam, KJ
Mujumdar, U
Hummer, AJ
Nobrega, J
Hawkins, WG
Coit, DG
Brady, MS
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
关键词
desmoplastic; melanoma; prognostic factors;
D O I
10.1097/01.pas.0000141391.91677.a4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Desmoplastic melanoma (DM) is a variant of melanoma, which may be confused with nonmelanocytic benign or malignant spindle cell proliferations. The histologic hallmark of DM is the presence of fusiform melanocytes dispersed in a prominent collagenous stroma. Phenotypic heterogeneity of DM is underrecognized. Desmoplasia may be prominent throughout the entire tumor ("pure" DM) or represent a portion of an otherwise nondesmoplastic melanoma ("combined" DM). We reviewed melanomas with desmoplasia from 92 patients seen at a single institution between 1980 and 2002. Fifty-five of the tumors were pure DM. Thirty-seven were classified as combined. Mean follow-up of patients was 46 months for those alive at the last follow-up. Univariate analysis of clinical and pathologic parameters revealed four significant variables for disease-free survival: Clark level (IV vs. V; P = 0.005), DM subtype (pure vs. combined; P = 0.01), tumor mitotic rate (<1, 1-4, >4 mitoses/mm(2); P = 0.01), and tumor thickness (<1 mm, 1-4 mm, >4 mm; P = 0.02). Only histologic subtype (P = 0.02) and Clark level (P = 0.05) were independently significant by Cox regression analysis. Our results indicate that distinguishing pure from combined forms of DM is clinically relevant for prognosis (pure forms being associated with longer disease-specific survival). Failure to make this distinction may account for conflicting reports in the literature on the biologic behavior and prognosis of DM.
引用
收藏
页码:1518 / 1525
页数:8
相关论文
共 35 条
[31]   Desmoplastic and neurotropic melanoma - Analysis of 33 patients with lymphatic mapping and sentinel lymph node biopsy [J].
Su, LD ;
Fullen, DR ;
Lowe, L ;
Wang, TS ;
Schwartz, JL ;
Cimmino, VM ;
Sondak, VK ;
Johnson, TM .
CANCER, 2004, 100 (03) :598-604
[32]   Evaluation of sentinel lymph node status in spindle cell melanomas [J].
Thelmo, MC ;
Sagebiel, RW ;
Treseler, PA ;
Morita, ET ;
Nguyen, LH ;
Kashani-Sabet, M ;
Leong, SPL .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (03) :451-455
[33]   Pitfalls in the diagnosis of malignant melanoma - Findings of a risk management panel study [J].
Troxel, DB .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (09) :1278-1283
[34]  
WALSH NMG, 1988, ARCH PATHOL LAB MED, V112, P922
[35]   Desmoplastic malignant melanoma, diagnosis of early clinical lesions [J].
Wharton, JM ;
Carlson, JA ;
Mihm, MC .
HUMAN PATHOLOGY, 1999, 30 (05) :537-542